Navigation Links
New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
Date:6/28/2010

cose-dependent mechanism of action, Victoza® is associated with a low rate of minor hypoglycemia. The mechanism of blood sugar lowering also involves a delay in gastric emptying.

Victoza® was approved by the U.S. Food and Drug Administration (FDA) on January 25, 2010 as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.  

Victoza® has also been approved by the European Commission in all 27 European Union member states.  As of June 2010, approval has also been granted by the regulatory authorities in Japan, Norway, Mexico, Iceland, Lebanon, Russia, Argentina, India, Brazil, Canada and Switzerland.  Victoza® has already been commercially launched in the U.S., UK, Japan, Germany, France and Denmark as well as a number of other European countries and will be available in other markets throughout 2010.  A New Drug Application was also submitted for approval in China in August 2009.  A regulatory decision is pending.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care.  The company also has leading positions within hemophilia care, growth hormone therapy and hormone therap
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)s Effect on Bone Quality in Osteoporotic Patients
2. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
3. Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension
4. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
5. Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer
6. Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB
7. Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection
8. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
9. Osseon Therapeutics Demonstrates to the European Medical Community How to Think Outside The Balloon When Treating Vertebral Compression Fractures
10. Adamas Pharmaceuticals TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models
11. New Data Demonstrates Abbotts Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Inc. (NYSE: DPLO ), the nation,s largest independent specialty ... 2015. All comparisons, unless otherwise noted, are to the quarter ... Highlights include: , Revenue of $808 million, an ... dispensed of 234,000, an increase of 19% , Gross ... $22.7 million, an increase of 287% or $16.8 million ...
(Date:8/3/2015)... 2015 OmniSeq, LLC today announced the ... OmniSeq SM Genomic Network.  Recently, OmniSeq officially ... and announced it was making available a suite ... approach to genomic diagnostics that provides actionable results ... a rapidly expanding, multidisciplinary cancer care center that ...
(Date:8/3/2015)... NEW YORK , August 3, 2015 /PRNewswire/ ... report published by Persistence Market Research "Global Market ... to Witness Highest Growth by 2022", ... at US$15 Bn by the end of 2015 and ... 6.8% from 2015 to 2022, to account for ...
Breaking Medicine Technology:Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4
... Safety of ,First Generation, Antisense, BERKELEY HEIGHTS, ... ) announced the presentation of new data showing,that ... be safely administered in high doses by a ... by Dr. Anthony Tolcher, Director,of Clinical Research, South ...
... for drug development services, WILMINGTON, N.C., Oct. ... opening of offices in Sydney, Australia;,Copenhagen, Denmark; Lisbon, ... Phase II-IV services in key therapeutic areas. ... footprint for,delivering clinical services in response to increasing ...
Cached Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal 2
(Date:8/3/2015)... ... August 04, 2015 , ... Approved ... extensive line up of live courses for the month of August. , Physical ... individually or by purchasing a Physical Therapy Flex package. Flex packages allow ...
(Date:8/3/2015)... ... ... the most affordable web design and SEO services for start up companies. Every start ... Every company that is starting out needs to be online in this technology advanced ... start up need to be online, they need to physically be present and visible online. ...
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is ... is the 20th sweetFrog store operating in the Lone Star State. The premium frozen ... companies in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will ...
(Date:8/3/2015)... ... August 03, 2015 , ... Code , an industry leader of ... a Bluetooth Code Reader accessory that enables a wireless connection between the CR5000 ... enable a variety of barcode reading applications with iPads, Galaxy Tabs, and many other ...
(Date:8/3/2015)... ... ... an opinion piece published July 28 by the Washington Post, the conventional wisdom ... may not be accurate. While this system may work for some people, the author notes ... both on the individual and at what point that person is in their weight loss ...
Breaking Medicine News(10 mins):Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:sweetFrog Reopens Texas Store Today 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2
... -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (,Lotus, or ... China,("PRC"), today announced financial results for the fourth quarter ... Quarter 2007 Highlights -- Total revenues increased to ... quarter of 2006 -- Gross profit ...
... life,sciences company based in Shanghai, China and Emeryville, ... several executive management appointments to,build out its global ... joined ProGenTech as its Vice President for R&D,based ... global R&D programs,and have accountability for the company,s ...
... HAMILTON, Bermuda, April 17 CRM Holdings,Ltd. ("the ... Compensation Risk,Managers, LLC ("CRM"), a wholly-owned subsidiary of ... Workers, Compensation Board (the "WCB"),that, following an initial ... action in order to revoke CRM,s third party,administrator,s ...
... Nurses,Association,s (CNA) insistence on presenting misleading and inaccurate,stories about ... (SEIU) reached new levels this week., Not only ... as evidence of,"violence by protesters" at the Labor Notes ... and members injured by conference security --,the union,s claims ...
... SANTA MONICA, Calif., April 16 Consumer,Watchdog today ... the,city,s lawsuit alleging that health insurer Blue Cross ... health insurance of patients,after they got sick., ... affected at least hundreds,of patients who have been ...
... Capitol Hill to Ask U.S. to,Meet Obligations to World,s ... Ribbon,Alliance for Safe Motherhood today took its call for ... Citing recent reports that the UN,Millennium Development Goal to ... be met in Asia until 2076 and many years ...
Cached Medicine News:Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 4Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 5Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 6Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 7Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 8Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 9Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 10Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 11Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 12Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 13Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 14Health News:ProGenTech Limited Appoints Executive Management Team 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 3Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage 2Health News:White Ribbon Alliance Calls for Investments to Save Women's Lives Lost in Pregnancy and Childbirth 2
... Alfa acetabular cup system has been designed ... a tri-spiked and cluster hole configurations. The ... minimize micromotion on three primary modes: Tilt, ... design features result in initial and long-term ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
Medicine Products: